Concepedia

Author

K. Kato

National Defense Medical College HospitalORCID

Also Known As

K Kato, K. Kato, KENTO KATO, Kento Kato

63

Publications

441

Citations

10

H-Index

27

Concepts

All Affiliations

National Defense Medical College HospitalNational Defense Medical College
KK

About

K. Kato is an author at National Defense Medical College Hospital specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

71

2

Engineering

1

1

10

3

Social Sciences

1

1

24

4

Cell Biology

1

1

17

5

Neurology

1

1

24

K. Kato

×

11

Publications

337

Citations

10

H-Index

YearCitations

Phase II Study of Concurrent Chemoradiotherapy at the Dose of 50.4 Gy with Elective Nodal Irradiation for Stage II-III Esophageal Carcinoma

K. Kato, Takako Eguchi Nakajima, Y. Ito,

Japanese Journal of Clinical Oncology

2013

90

Pretreatment Neutrophil-to-Lymphocyte Ratio Was a Predictor of Lymph Node Metastasis in Endometrial Cancer Patients

Tadashi Aoyama, Masashi Takano, Morikazu Miyamoto,

Oncology

2019

79

Unilateral or bilateral nerve-sparing radical hysterectomy: a surgical technique to preserve the pelvic autonomic nerves while increasing radicality

K. Kato, Kiyomi Suzuka, Takashi Osaki,

International Journal of Gynecological Cancer

2007

42

Basic study of brain injury mechanism caused by cavitation

Y. Kurosawa, K. Kato, S Saito,

2009

24

Phenoxodiol Increases Cisplatin Sensitivity in Ovarian Clear Cancer Cells Through XIAP Down-regulation and Autophagy Inhibition

Morikazu Miyamoto, Masashi Takano, Tadashi Aoyama,

Anticancer Research

2018

20

Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy?

Tadashi Aoyama, Masashi Takano, Morikazu Miyamoto,

Cancer Chemotherapy and Pharmacology

2017

19

Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle as second-line treatment for advanced or recurrent gastric cancer.

Koei Chin, K. Kato, T. Yoshikawa,

Journal of Clinical Oncology

2010

17

A Pathological Study Using 2014 WHO Criteria Reveals Poor Prognosis of Grade 3 Ovarian Endometrioid Carcinomas

Hiroaki Soyama, Morikazu Miyamoto, Masashi Takano,

In Vivo

2018

14

Role of endometriosis as a prognostic factor for post‑progression survival in ovarian clear cell carcinoma

Hiroki Ishibashi, Masashi Takano, Morikazu Miyamoto,

Molecular and Clinical Oncology

2017

11

Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: a retrospective analysis

Kazuki Takasaki, Morikazu Miyamoto, Masashi Takano,

Cancer Chemotherapy and Pharmacology

2018

11

Page 1